111 related articles for article (PubMed ID: 24953525)
41. A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3.
Delaunay JL; Durand-Schneider AM; Dossier C; Falguières T; Gautherot J; Davit-Spraul A; Aït-Slimane T; Housset C; Jacquemin E; Maurice M
Hepatology; 2016 May; 63(5):1620-31. PubMed ID: 26474921
[TBL] [Abstract][Full Text] [Related]
42. Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3/ABCB4.
Yoshikado T; Takada T; Yamamoto T; Yamaji H; Ito K; Santa T; Yokota H; Yatomi Y; Yoshida H; Goto J; Tsuji S; Suzuki H
Mol Pharmacol; 2011 Feb; 79(2):241-50. PubMed ID: 21056966
[TBL] [Abstract][Full Text] [Related]
43. Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models.
Vauthier V; Ben Saad A; Elie J; Oumata N; Durand-Schneider AM; Bruneau A; Delaunay JL; Housset C; Aït-Slimane T; Meijer L; Falguières T
Sci Rep; 2019 Apr; 9(1):6653. PubMed ID: 31040306
[TBL] [Abstract][Full Text] [Related]
44. Paucity of Interlobular Bile Ducts in Multidrug-Resistant P-Glycoprotein 3 (MDR3) Deficiency.
Vij M; Valamparampil J; Shanmugum N; Reddy SM; Rajindrajith S; Rela M
Int J Surg Pathol; 2019 May; 27(3):343-347. PubMed ID: 30222019
[TBL] [Abstract][Full Text] [Related]
45. Clinical outcomes of ABCB4 heterozygosity in infants and children with cholestatic liver disease.
Hegarty R; Gurra O; Tarawally J; Allouni S; Rahman O; Strautnieks S; Kyrana E; Hadzic N; Thompson RJ; Grammatikopoulos T
J Pediatr Gastroenterol Nutr; 2024 Feb; 78(2):339-349. PubMed ID: 38374565
[TBL] [Abstract][Full Text] [Related]
46. Thyroid hormone receptor β1 stimulates
Gautherot J; Claudel T; Cuperus F; Fuchs CD; Falguières T; Trauner M
J Lipid Res; 2018 Sep; 59(9):1610-1619. PubMed ID: 29895698
[TBL] [Abstract][Full Text] [Related]
47. Low phospholipid-associated cholestasis and cholelithiasis.
Erlinger S
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S36-40. PubMed ID: 23141892
[TBL] [Abstract][Full Text] [Related]
48. The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis.
Hochrath K; Krawczyk M; Goebel R; Langhirt M; Rathkolb B; Micklich K; Rozman J; Horsch M; Beckers J; Klingenspor M; Fuchs H; Gailus-Durner V; Wolf E; Acalovschi M; Volmer DA; Hrabě de Angelis M; Lammert F
FASEB J; 2012 Dec; 26(12):5081-91. PubMed ID: 22982378
[TBL] [Abstract][Full Text] [Related]
49. In silico investigation of the impact of synonymous variants in ABCB4 gene on mRNA stability/structure, splicing accuracy and codon usage: Potential contribution to PFIC3 disease.
Khabou B; Siala-Sahnoun O; Gargouri L; Mkaouar-Rebai E; Keskes L; Hachicha M; Fakhfakh F
Comput Biol Chem; 2016 Dec; 65():103-109. PubMed ID: 27788395
[TBL] [Abstract][Full Text] [Related]
50. A novel compound heterozygous mutation in ABCB4 gene in a pedigree with progressive familial intrahepatic cholestasis 3: a case report.
Bai J; Li L; Liu H; Liu S; Bai L; Ning H; Song W; Zou H; Wang X; Chen Y; Zheng S; Duan Z
Ann Transl Med; 2021 Mar; 9(5):426. PubMed ID: 33842647
[TBL] [Abstract][Full Text] [Related]
51. A letter on ABCB4 from Iceland: On the highway to liver disease.
Lammert F; Hochrath K
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):655-8. PubMed ID: 26410236
[TBL] [Abstract][Full Text] [Related]
52. The Multiple Facets of ABCB4 (MDR3) Deficiency.
Sundaram SS; Sokol RJ
Curr Treat Options Gastroenterol; 2007 Dec; 10(6):495-503. PubMed ID: 18221610
[TBL] [Abstract][Full Text] [Related]
53. Novel
Liu TF; He JJ; Wang L; Zhang LY
World J Clin Cases; 2022 Feb; 10(6):1998-2006. PubMed ID: 35317165
[TBL] [Abstract][Full Text] [Related]
54. ABCB4 deficiency: A family saga of early onset cholelithiasis, sclerosing cholangitis and cirrhosis and a novel mutation in the ABCB4 gene.
Denk GU; Bikker H; Lekanne Dit Deprez RH; Terpstra V; van der Loos C; Beuers U; Rust C; Pusl T
Hepatol Res; 2010 Sep; 40(9):937-41. PubMed ID: 20887599
[TBL] [Abstract][Full Text] [Related]
55. Monomeric bile acids modulate the ATPase activity of detergent-solubilized ABCB4/MDR3.
Kroll T; Smits SHJ; Schmitt L
J Lipid Res; 2021; 62():100087. PubMed ID: 34022183
[TBL] [Abstract][Full Text] [Related]
56. Receptor for activated C-kinase 1 regulates the cellular localization and function of ABCB4.
Ikebuchi Y; Takada T; Ito K; Yoshikado T; Anzai N; Kanai Y; Suzuki H
Hepatol Res; 2009 Nov; 39(11):1091-107. PubMed ID: 19674157
[TBL] [Abstract][Full Text] [Related]
57. Comparison of in silico prediction and experimental assessment of ABCB4 variants identified in patients with biliary diseases.
Khabou B; Durand-Schneider AM; Delaunay JL; Aït-Slimane T; Barbu V; Fakhfakh F; Housset C; Maurice M
Int J Biochem Cell Biol; 2017 Aug; 89():101-109. PubMed ID: 28587926
[TBL] [Abstract][Full Text] [Related]
58. Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model.
Weber ND; Odriozola L; Martínez-García J; Ferrer V; Douar A; Bénichou B; González-Aseguinolaza G; Smerdou C
Nat Commun; 2019 Dec; 10(1):5694. PubMed ID: 31836711
[TBL] [Abstract][Full Text] [Related]
59. Molecular basis of progressive familial intrahepatic cholestasis 3. A proteomics study.
Guerrero L; Carmona-Rodríguez L; Santos FM; Ciordia S; Stark L; Hierro L; Pérez-Montero P; Vicent D; Corrales FJ
Biofactors; 2024 Jan; ():. PubMed ID: 38284625
[TBL] [Abstract][Full Text] [Related]
60. Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction.
Degiorgio D; Corsetto PA; Rizzo AM; Colombo C; Seia M; Costantino L; Montorfano G; Tomaiuolo R; Bordo D; Sansanelli S; Li M; Tavian D; Rastaldi MP; Coviello DA
Eur J Hum Genet; 2014 May; 22(5):633-9. PubMed ID: 24045840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
